Yuanquan Yang
Clinical trials sponsored by Yuanquan Yang, explained in plain language.
-
Can a simple infusion stop Immunotherapy's worst side effects?
Disease control Recruiting nowThis study tests whether giving siltuximab (a drug that lowers inflammation) can prevent severe immune-related side effects when restarting immunotherapy in 40 adults with advanced cancer. Participants previously had serious side effects from immunotherapy and are now at high ris…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New drug duo offers hope for bladder cancer patients who can't take chemo
Disease control Recruiting nowThis study tests whether combining futibatinib (a targeted therapy) with durvalumab (an immunotherapy) before bladder removal surgery can help people with muscle-invasive bladder cancer who cannot receive standard cisplatin chemotherapy. About 24 participants will receive the dru…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated May 26, 2026 08:31 UTC